On the probable association of adalimumab and diffuse retinopathy in a patient with Crohn's disease.
Andreas
A
Katsanos
Ioannis
I
Asproudis
Konstantinos
K
Katsanos
Epameinondas V
EV
Tsianos
D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D012164:Retinal Diseases / Q000139:chemically induced*; D014786:Vision Disorders / Q000139:chemically induced*
D000893:Anti-Inflammatory Agents; D061067:Antibodies, Monoclonal, Humanized